T-group (topology)
883.1.1 Aha1/BPI domain-like
Ligands and drugs
926
Member domains
76
with ligand contacts (≤ 4 Å)
8.2% of members
68
with DrugDomain annotations
7.3% of members
41
with a DrugBank compound
4.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 883.1.1 belongs to X-group 883 Aha1/BPI domain-like, which has 13 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04327 | PEE | Phosphatidylethanolamine | 10 |
| DB03690 | PCW | (Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide | 4 |
| DB00141 | NAG | N-Acetylglucosamine | 3 |
| DB04372 | DLP | L-Dilinoleoyllecithin | 2 |
| DB06281 | 0RP | Torcetrapib | 2 |
| DB08231 | MYR | Myristic acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 13 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 10 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 8 |
| 2OB | CHOLESTERYL OLEATE | 6 |
| 6OU | [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate | 4 |
| CL | CHLORIDE ION | 4 |
| Kmetal | POTASSIUM ION | 4 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 4 |
| PCW | 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 4 |
| ZNmetal | ZINC ION | 4 |
| CAmetal | CALCIUM ION | 3 |
| 0RP | ethyl(2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate | 2 |
| 0SF | (2R)-3-{[4-(4-chloro-3-ethylphenoxy)pyrimidin-2-yl][3-(1,1,2,2-tetrafluoroethoxy)benzyl]amino}-1,1,1-trifluoropropan-2-ol | 2 |
| BCR | BETA-CAROTENE | 2 |
| DLP | 1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 2 |
| EGC | 2-(2-{2-[2-(2-{2-[2-(2-{2-[4-(1,1,3,3-TETRAMETHYL-BUTYL)-PHENOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL | 2 |
| JH2 | methyl (2E,6E)-9-[(2R,3S)-3-ethyl-3-methyloxiran-2-yl]-3,7-dimethylnona-2,6-dienoate | 2 |
| MYR | MYRISTIC ACID | 2 |
| OLA | OLEIC ACID | 2 |
| UQ8 | Ubiquinone-8 | 2 |